International SARS-CoV-2 Infection Observational Study (ICOS)

Tahapan Penelitian : Awal
Sponsor:
Mitra Pelaksana:
INA-RESPOND, RSUP dr. Wahidin SUdirohusodo dan RSUPN Dr.Cipto Mangunkusumo
No Registry
INA-2GHFOKN
Tanggal Input Registry : 26-10-2020

27-10-2020
1. Estimate the rate of hospitalization or death during the 28-day follow-up period. 2. Identify risk factors for hospitalization or death.
1. Estimate the proportion of screened adults who test positive for SARS-CoV-2. 2. Compare characteristics between those who test virus positive versus those who test negative for the global cohort and by geographic region: o demographics o co-morbid conditions or immunosuppression o risk factors for death from COVID-19.
 
International SARS-CoV-2 Infection Observational Study (ICOS)
International SARS-CoV-2 Infection Observational Study (ICOS)
Observasional
Tidak ada Intervensi
500
 

Inclusion Criteria:

1. ≥ 18 years of age. 2. Not hospitalized. 3. Signed informed consent.

Exclusion Criteria:

Persons with a known positive SARS-CoV-2 test > 28 days ago.
 
(NIHRD-IRB) Komisi Etik Penelitian Kesehatan Badan Penelitian dan Pengembangan Kesehatan: No. LB.02.01/2/KE.520/2020 tertanggal 10 Agustus 2020
Tidak berlaku
Tidak Berlaku
INSIGHT-011 ICOS
Dr. Muhammad Karyana, M.Kes; National PI: Prof. dr. Pratiwi P. Sudarmono, Ph.D.,SpMK(K)